| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4238058 | Journal of Vascular and Interventional Radiology | 2014 | 13 Pages |
Abstract
CT perfusion showed early reduction of AP in liver metastases responding to transarterial radioembolization; tumor diameter remained unchanged early after treatment. No significant early treatment response to transarterial radioembolization was found in patients with HCC. In patients with liver metastases, a decrease of AP after transarterial radioembolization was associated with a higher 1-year overall survival rate.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Caecilia S. MD, Fabian MD, Bert-Ram MD, Gilbert MD, Niklaus MD, Thomas MD, Hatem MD, MPH,